PDG8 The Cost-Effectiveness of Direct-Acting Antivirals Coverage Policies for Patients with Hepatitis C VIRUS Infection in Taiwan

Abstract

Authors

W.J. Kuo H.C. Lang

Full Text Cite This Article
Back to Volume 22, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×